(Q43452813)

English

Diminished CD4+/CD25+ T cell and increased IFN-gamma levels occur in dogs vaccinated with Leishmune in an endemic area for visceral leishmaniasis

scientific article published on 21 January 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

23 November 2017

Diminished CD4+/CD25+ T cell and increased IFN-gamma levels occur in dogs vaccinated with Leishmune in an endemic area for visceral leishmaniasis (English)

1 reference

Europe PubMed Central

23 November 2017

visceral leishmaniasis

1 reference

based on heuristic

inferred from title

7

1 reference

Europe PubMed Central

23 November 2017

author name string

Valéria Marçal Felix de Lima

1

1 reference

Europe PubMed Central

23 November 2017

Fabiana Augusta Ikeda

2

1 reference

Europe PubMed Central

23 November 2017

Cláudio N Rossi

3

1 reference

Europe PubMed Central

23 November 2017

Mary Marcondes Feitosa

4

1 reference

Europe PubMed Central

23 November 2017

Rosemeride Oliveira Vasconcelos

5

1 reference

Europe PubMed Central

23 November 2017

Caris Maroni Nunes

6

1 reference

Europe PubMed Central

23 November 2017

publication date

21 January 2010

1 reference

Europe PubMed Central

23 November 2017

Veterinary Immunology and Immunopathology

1 reference

Europe PubMed Central

23 November 2017

135

1 reference

Europe PubMed Central

23 November 2017

3-4

1 reference

Europe PubMed Central

23 November 2017

296-302

1 reference

Europe PubMed Central

23 November 2017

T-cell-derived cytokines, nitric oxide production by peripheral blood monocytes and seric anti-Leishmania (Leishmania) chagasi IgG subclass patterns following immunization against canine visceral leishmaniasis using Leishvaccine and Leishmune

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.12.008

7 January 2021

The role of CD4(+)CD25(+) regulatory T cells in Leishmania infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.12.008

7 January 2021

The fucose-mannose ligand-ELISA in the diagnosis and prognosis of canine visceral leishmaniasis in Brazil

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.12.008

7 January 2021

Long lasting protection against canine kala-azar using the FML-QuilA saponin vaccine in an endemic area of Brazil (S�o Gon�alo do Amarante, RN)

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.12.008

7 January 2021

Effective humoral and cellular immunoprotective responses in Li ESAp-MDP vaccinated protected dogs.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.12.008

7 January 2021

Demonstration of Leishmania specific cell mediated and humoral immunity in asymptomatic dogs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.12.008

7 January 2021

Immunization strategies against visceral leishmaniosis with the nucleosomal histones of Leishmania infantum encoded in DNA vaccine or pulsed in dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.12.008

7 January 2021

A phase III trial of efficacy of the FML-vaccine against canine kala-azar in an endemic area of Brazil (São Gonçalo do Amaranto, RN).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.12.008

7 January 2021

Comparison of three assays for the evaluation of specific cellular immunity to Leishmania infantum in dogs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.12.008

7 January 2021

Reactivity of antibodies directed against human antigens with surface markers on canine leukocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.12.008

7 January 2021

Leishmania donovani: identification of stimulatory soluble antigenic proteins using cured human and hamster lymphocytes for their prophylactic potential against visceral leishmaniasis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.12.008

7 January 2021

An update on antileishmanial vaccine candidates and prospects for a canine Leishmania vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.12.008

7 January 2021

Clinical and parasitological evaluation of dogs naturally infected by Leishmania (Leishmania) chagasi submitted to treatment with meglumine antimoniate

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.12.008

7 January 2021

Multiplex analysis of circulating cytokines in the sera of patients with different clinical forms of visceral leishmaniasis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.12.008

7 January 2021

Anti-leishmania antibodies in cerebrospinal fluid from dogs with visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.12.008

7 January 2021

Responses to Leishmania donovani in mice deficient in interleukin-12 (IL-12), IL-12/IL-23, or IL-18

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.12.008

7 January 2021

Leishmune vaccine blocks the transmission of canine visceral leishmaniasis: absence of Leishmania parasites in blood, skin and lymph nodes of vaccinated exposed dogs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.12.008

7 January 2021

Splenic accumulation of IL-10 mRNA in T cells distinct from CD4+CD25+ (Foxp3) regulatory T cells in human visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.12.008

7 January 2021

Leishmania donovani surface glycoconjugate GP36 is the major immunogen component of the Fucose-Mannose Ligand (FML)

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.12.008

7 January 2021

Leishmania donovani: titration of antibodies to the fucose-mannose ligand as an aid in diagnosis and prognosis of visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.12.008

7 January 2021

Leishmania infantum-specific T cell lines derived from asymptomatic dogs that lyse infected macrophages in a major histocompatibility complex-restricted manner.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.12.008

7 January 2021

Amplification of kinetoplast DNA as a tool in the detection and diagnosis of Leishmania

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.12.008

7 January 2021

Identification of regulatory T cells during experimental Leishmania infantum infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.12.008

7 January 2021

Despite Leishvaccine and Leishmune trigger distinct immune profiles, their ability to activate phagocytes and CD8+ T-cells support their high-quality immunogenic potential against canine visceral leishmaniasis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.12.008

7 January 2021

Distinct roles for IL-6 and IL-12p40 in mediating protection against Leishmania donovani and the expansion of IL-10+ CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.12.008

7 January 2021

Leishmania chagasi antigens recognized in cured visceral leishmaniasis and asymptomatic infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.12.008

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VETIMM.2009.12.008

1 reference

Europe PubMed Central

23 November 2017

1 reference

Europe PubMed Central

23 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43452813&oldid=1989088479"